Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

393
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
393
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

349
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
349
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

277
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

330
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
330
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

219
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

327
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
327

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Denominator bias in MENA MASLD epidemiology: A call for decision-grade surveillance.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2026
Same author

Unveiling the supramolecular assembly of a novel antimony(iii)-based co-crystal: integrating multi-spectroscopic analyses, DFT calculations, and advanced biological evaluations.

RSC advances·2026
Same author

Structural, optical, thermal, and computational insights into the 1D antimony-based hybrid perovskite (C<sub>10</sub>H<sub>13</sub>N<sub>4</sub>)[SbI<sub>4</sub>]·H<sub>2</sub>O.

RSC advances·2026
Same author

Complete pathological response to neoadjuvant chemoradiotherapy in Crohn's disease-associated fistula adenocarcinoma: a case report.

Frontiers in medicine·2026
Same author

Structural elucidation and interaction profiling of a novel bismuth-based organic-inorganic hybrid: (C<sub>8</sub>H<sub>14</sub>N<sub>2</sub>)<sub>3</sub>(BiCl<sub>6</sub>)<sub>2</sub>.

RSC advances·2026
Same author

A new multifunctional one-dimensional bromo-bismuthate(iii): synthesis, structural features, characterization, and optical properties of (C<sub>10</sub>H<sub>13</sub>N<sub>4</sub>)[BiBr<sub>4</sub>]·2H<sub>2</sub>O.

RSC advances·2026
Same journal

Abstracts International Scientific Day on Oxidative Stress, Aging, and Age-Related Diseases.

La Tunisie medicale·2026
Same journal

Pharmacological evaluation of anti-inflammatory potential and antispasmodic effect of aqueous extract from the brown seaweed, Cystoseira compressa.

La Tunisie medicale·2026
Same journal

Assessing the Accuracy of LDL-Cholesterol Estimation Formulas in the Tunisian Population.

La Tunisie medicale·2026
Same journal

Assessment of liver fibrosis in Chronic hepatitis B: performance of hematological parameters.

La Tunisie medicale·2026
Same journal

Association between Oxidative Stress, Cardiovascular Risk, and Disease Activity in Patients with Spondyloarthritis: A Cross-Sectional Study in a Tunisian Cohort.

La Tunisie medicale·2026
Same journal

Assessment of oral cancer awareness among dentists in Tunisia: A cross-sectional study.

La Tunisie medicale·2026
See all related articles

Related Experiment Video

Updated: Dec 21, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.1K

Cirrhotic cardiomyopathy.

Nour Elleuch, Soumaya Mrabet, Aida Ben Slama

    La Tunisie Medicale
    |May 13, 2020
    PubMed
    Summary
    This summary is machine-generated.

    Cirrhotic cardiomyopathy (CCM) is a cardiac dysfunction in cirrhosis patients, often latent and underdiagnosed. Early recognition and management are crucial for improving outcomes in liver disease.

    More Related Videos

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
    05:14

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

    Published on: May 16, 2020

    5.2K
    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
    10:08

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

    Published on: February 17, 2018

    13.9K

    Related Experiment Videos

    Last Updated: Dec 21, 2025

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
    03:45

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

    Published on: August 8, 2022

    4.1K
    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
    05:14

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

    Published on: May 16, 2020

    5.2K
    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
    10:08

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

    Published on: February 17, 2018

    13.9K

    Area of Science:

    • Cardiology
    • Hepatology
    • Internal Medicine

    Background:

    • Cardiovascular dysfunction in liver cirrhosis was historically attributed solely to alcoholic cardiomyopathy.
    • The term cirrhotic cardiomyopathy (CCM) emerged in the last two decades to define cardiac dysfunction specific to cirrhosis.
    • CCM is often latent, presenting under stress, leading to underdiagnosis.

    Purpose of the Study:

    • To provide a comprehensive overview of cirrhotic cardiomyopathy (CCM).
    • To discuss the definition, prevalence, pathogenesis, clinical presentation, diagnostic tools, and management of CCM.
    • To review the latest literature on CCM.

    Main Methods:

    • Literature review of recent publications on cirrhotic cardiomyopathy.
    • Synthesis of information regarding CCM's characteristics and clinical implications.

    Main Results:

    • CCM is characterized by systolic and diastolic dysfunction, along with electrophysiological abnormalities.
    • Overt cardiac failure can occur post-transjugular intrahepatic portosystemic shunt (TIPS) and liver transplantation.
    • Diagnosis remains challenging due to a lack of specific diagnostic tools.

    Conclusions:

    • CCM is a significant complication of liver cirrhosis with no specific treatment beyond liver transplantation.
    • Increased mortality and postoperative complications are associated with CCM.
    • Further research is needed for improved diagnosis and management strategies for CCM.